Thomas A. Pearson

Translation of nutritional sciences into medical education: the Nutrition Academic Award Program 1–3 (2008)

Thomas A Pearson, Elaine J Stone, Scott M Grundy, Patrick E Mcbride, Linda Van Horn, Brian W Tobin

ABSTRACT For the past 40 y the scientific community has decried the inadequacy of the training of physicians and other health professionals in the subject of human nutrition. In 1997 the National...

Guidelines in Rural Practices: Model System for Managed Care (2008)

Roberta G. Reed, Sophia V. Fong, Thomas A. Pearson

We describe the use of a central laboratory to identify patients who may be candidates for a hypercholesterolemia treatment program and to direct their referral into this program. The laboratory,...

Guide to Preventive Cardiology for Women (2008)

Lori Mosca, Scott M. Grundy, Debra Judelson, Kathleen King, Marian Limacher, Suzanne Oparil, ...

Subscriptions: Information about subscribing to Circulation is online at

An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial (2007)

Wang, Thomas H., Bhatt, Deepak L., Fox, Keith A.A., Steinhubl, Steven R., Brennan, Danielle M., Hacke, Werner, ...

Aims To examine the unanticipated, excess mortality observed in patients randomized to clopidogrel and aspirin vs. aspirin alone in the prespecified ‘asymptomatic’ subgroup of CHARISMA, we...

Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years (2007)

Nafziger, Anne N, Lindvall, Kristina, Norberg, Margareta, Stenlund, Hans, Wall, Stig, Jenkins, Paul L, ...

Abstract Background Obesity has primarily been addressed with interventions to promote weight loss and these have been largely unsuccessful. Primary prevention of obesity through support of weight...

Costimulation requirements for antiviral CD8+ T cells differ for acute and persistent phases of polyoma virus infection (2006)

Kemball, Christopher C., Lee, Eun D. Han, Szomolanyi-Tsuda, Eva, Pearson, Thomas A., Larsen, Christian P., Lukacher, Aron E.

The requirement for costimulation in antiviral CD8+ T cell responses has been actively investigated for acutely resolved viral infections, but it is less defined for CD8+ T cell responses to...

Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: medical office assessment: Writing Group I (2000)

Grundy, Scott M., Bazzarre, Terry, Cleeman, James, D'Agostino, Ralph B., Hill, Martha, Miller, Nancy Houston, ...

Writing Group I of Prevention Conference V reviewed the role of medical office assessment in the detection of risk factors and estimation of total cardiovascular risk. The primary focus was on...

Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association (1998)

Grundy, Scott M., Balady, Gary J., Criqui, Michael H., Fletcher, Gerald F., Greenland, Philip, Hiratzka, Loren F., ...

This statement discusses the new Framingham Heart Study charts for estimating (CHD) coronary heart disease risk, their essential features, and their appropriate use. In addition, several issues...

Rural Epidemiology: Insights from a Rural Population Laboratory (1998)

Pearson, Thomas A., Lewis, Carol

To study the epidemiology of rural populations in the context of contemporary issues in public health, a population laboratory (Health Census '89) was established in Otsego County, New York, by the...

When to start cholesterol-lowering therapy in patients with coronary heart disease. A statement for healthcare professionals from the American Heart Association Task Force on Risk Reduction (1997)

Grundy, Scott M., Balady, Gary J., Criqui, Michael H., Fletcher, Gerald F., Greenland, Philip, Hiratzka, Loren F., ...

At present a large number of patients with atherosclerotic disease are not receiving aggressive cholesterol-lowering therapy. Consequently they are being deprived of a cost-effective, risk-reducing...

Characteristics of a Hypothetical Group of Hospital Controls for a Case-Control Study (1994)

Olson, Sara H., Kelsey, Jennifer L., Pearson, Thomas A., Levin, Bruce

In case-control studies in which cases are ascertained from hospitals, controls are frequently chosen from among patients with other diseases at the same hospitals. This study was undertaken to...

Evaluation of Random Digit Dialing as a Method of Control Selection in Case-Control Studies (1992)

Olson, Sara H., Kelsey, Jennifer L., Pearson, Thomas A., Levin, Bruce

Control groups selected by random digit dialing are frequently used in case–control studies. Concern about the potential for bias in these control groups has been expressed, primarily because of...

THE EPIDEMIOLOGY OF IDIOPATHIC DILATED CARDIOMYOPATHY IN A BIRACIAL COMMUNITY (1990)

COUGHLIN, STEVEN S., SZKLO, MOYSES, BAUGHMAN, KENNETH, PEARSON, THOMAS A.

An epidemiologic study of idiopathic dilated cardiomyopathy was carried out in order to identity possible risk factors for this often fatal cause of heart failure in young adults. Possible...

THE ASSOCIATION OF RISK FACTORS WITH ARTERIOGRAPHICALLY DEFINED CORONARY ARTERY DISEASE: WHAT IS THE APPROPRIATE CONTROL GROUP? (1987)

FRIED, LINDA P., PEARSON, THOMAS A.

Although the use of arteriography to define coronary artery disease is considered the optimal method for determining associations of risk factors with atherosclerosis, the strengths of associations...

High Levels of Inflammatory Biomarkers Are Associated with Increased Allele-Specific Apolipoprotein(a) Levels in African-Americans

Anuurad, Erdembileg, Rubin, Jill, Chiem, Alan, Tracy, Russell P., Pearson, Thomas A., Berglund, Lars

Background: A role of inflammation for cardiovascular disease (CVD) is established. Lipoprotein(a) [Lp(a)] is an independent CVD risk factor where plasma levels are determined by the...